Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yes we are APHRIA $trong $$$
No news until now , but we are at the right place at the right time imo
GLTA !
APH $$$$$$
Can’t go wrong with APHRIA
https://grizzle.com/wp-content/uploads/2018/10/Grizzle_Aphria_Conviction_Call_Report_FNL-V02.pdf
thank you, DayGrinder.... will fly over there now...
More news and discussion on the other APH forum
https://investorshub.advfn.com/Aphria-Inc-APHQF-31329/
Any news on Friday's meeting...?
Today is an example of true leadership, a company that files for NYSE to uplist a week after the overhyped oct 17 after the smoke has cleared compare to a company that rushes in without thinking. Imho
According to NASDAQ premkt - APHA trades at $12.00 US..GOOOOOOO Aphria !!!!!!!!!!!!!!!!!!!!!!!!!
Althea granted license
https://aphria.ca/blog/aphrias-australian-based-partner-althea-granted-manufacture-licence/
Thst‘s awesome Bud
APH $$$$$$$
Big day today here... and a big night too...
Thanks buddy! Best of luck to you today and all! We are with the 'Big Boys' now! I think the day will be decent compared to aurora's debut,, already early market trading up,, I hope Vic has a surprise pre-market still,, if not maybe after hours PR.
$inai
$$$$$APH$$$$$
61% increase
Today (01-Nov-18) Financial Times APH share price forecast:
The 7 analysts offering 12 month price targets for Aphria Inc have a median target of 24.50, with a high estimate of 32.00 and a low estimate of 16.50. The median estimate represents a 61.72% increase from the last price of 15.15.
Consensus recommendation
As of Oct 26, 2018, the consensus forecast amongst 7 polled investment analysts covering Aphria Inc advises investors to purchase equity in the company. This has been the consensus forecast since the sentiment of investment analysts improved on Sep 26, 2018. The previous consensus forecast advised that Aphria Inc would outperform the market.
https://markets.ft.com/data/equities/tearsheet/forecasts?s=APH:TOR
Aphria's Australian-Based Partner Althea Granted Manufacture Licence
NEWS PROVIDED BY
Aphria Inc.
Nov 01, 2018, 23:43 ET
LEAMINGTON, ON, Nov. 1, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) today announced that its Australian-based partner Althea Company Pty Ltd. ("Althea" or the "Australian Company") has been granted a Manufacture Licence by the Australian Government's Office of Drug Control.
The license provides Althea with authorization to manufacture extracts and tinctures of cannabis and cannabis resin in accordance with relevant manufacture permits.
"We are excited to see our Australian partner achieve yet another milestone in receiving its Manufacture License. This is another step towards ensuring Australian patients have access to high-quality medicinal cannabis," said Vic Neufeld, CEO of Aphria.
"Althea is excited at receiving our Manufacture Licence. Coupled with the existing Medicinal Cannabis Licence, Althea can now proceed with the next phase of planning for our Victorian-based production facility. Althea shareholders can look forward to a vertically integrated, seed-to-sale, state of the art medicinal cannabis operation, comparable to that of our Canadian partner Aphria," said Althea CEO Josh Fegan.
"The granting of our Manufacture Licence adds to our growing momentum. Patients approved for Althea medicinal cannabis products have quickly passed the recent 100 patient milestone, with 127 patients now approved. Similarly, the number of doctors prescribing Althea products has increased from 42 to 50 in the last two weeks," said Mr. Fegan. "And we are only getting started. Our aim is to reach 1,000 patients by this time next year and the comprehensive work we are doing educating mainstream doctors across Australia, makes that a distinct possibility."
Through a previously announced exclusive supply agreement with Aphria, Althea commenced importing and supplying five co-branded medicinal products to eligible patients in Australia in the form of cannabis oil and dried flower, generating sales revenue starting in May 2018.
We Have A Good Thing Growing
About Aphria
Aphria is a leading global cannabis company driven by an unrelenting commitment to our people, product quality and innovation. Headquartered in Leamington, Ontario – the greenhouse capital of Canada – Aphria has been setting the standard for the low-cost production of safe, clean and pure pharmaceutical-grade cannabis at scale, grown in the most natural conditions possible. Focusing on untapped opportunities and backed by the latest technologies, Aphria is committed to bringing breakthrough innovation to the global cannabis market. The Company's portfolio of brands is grounded in expertly-researched consumer insights designed to meet the needs of every consumer segment. Rooted in our founders' multi-generational expertise in commercial agriculture, Aphria drives sustainable long-term shareholder value through a diversified approach to innovation, strategic partnerships and global expansion, with a presence in more than 10 countries across 5 continents.
For more information, visit: aphria.ca
About Althea
Althea was founded in Melbourne in 2017 with a view to acquiring the necessary licences and permits to import, cultivate, produce and supply medicinal cannabis for eligible patients across Australia. Through strategic supply and distribution partnerships, Althea has been able to commence sales of five Althea branded medicinal cannabis products in Australia.
Althea's focus on patient care underpins its business strategy and its innovative web-based platform and mobile application, known as Althea Concierge, is designed to educate and support patient access to medicinal cannabis in Australia. Althea has also engaged a team of medical science liaisons to assist medical practitioners to become prescribers, and pharmacists to become suppliers, of Althea products.
Glta
$inai
$$$$$APH$$$$$
Yes Germany will be big in Medical Marijuana...but bigger when they legalize Recreational:
https://www.medicalmarijuanainc.com/germany-marijuana-laws/
Aphria Inc (OTCMKTS:APHQF, TSE:APH) seems like the most likely cannabis company to team up with Diageo. At its November 2 annual meeting, Aphria will be nominating Tom Looney to its board of directors. Looney recently retired as President of Diageo U.S. Spirits and Canada. (Source: “NOTICE OF MEETING AND MANAGEMENT INFORMATION CIRCULAR FOR THE ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS to be held on November 2, 2018,” Aphria Inc, September 24, 2018.)
“From sales, Germany could have bigger market significance than Canada one day,” says Vic Neufeld, the CEO of Aphria,
https://global.handelsblatt.com/companies/canadian-companies-german-cannabis-market-977462
Shareholders Meeting:
Friday, November 2, 2018 shareholders will be asked to have Tom Looney and others on the board of directors...Why? Aphria would NOT do this if they didn't have a deal with Diageo.
Yes tomorrow will be decent with or without the big news we are all waiting for IMO,, APH is 'MUCH' undervalued compared to Aurora and market is starting to turn around as a whole,, one PR Premarket tomorrow and we gap up minimum 2-3$+ ,, if we have a normal green day tomorrow I believe Next Monday will be more explosive and results of AGM are posted.
Best of luck to all and still hoping for a 'turn around' during today's power hour!
$inai
$$$$$APH$$$$$
I think we will close -1.5% down today BUT that's okay...BIG DAY tomorrow.
Will close green today ahead of tomorrow debut and shareholders meeting
Yes..now that You mentioned it I just looked and it is a company called Amphenol.
Thank You Jmk2454.
APH was already taken by another company on the NYSE. It wasn’t available for Aphria.
I decided to check it out further...and was extremely surprised.
Figured the Ticker would be APH for sure.
Thanks Goodbuddy as I was wondering myself about the 4 letters,, haha,,, let's just stay over $13+ today!I will take it,, what a week.
$inai
$$$$$APH$$$$$
Good info thanks
Now...We have the Answer.
November 2nd, 2018 will be listed on the NYSE.
Usually the NYSE only has 3 letter or less in the Ticker.
Aphria is special...!!!
WOW...Rules changed in 2009.
https://www.wsj.com/articles/SB124296050986346159
I was unaware?
Agreed Bums!,,,I still believe there is a deal somewhere and possibly already Shaken Hands,, just wish he would have dropped 'the bomb' when pps was higher,, a multi deal would quickly get us close to $20 or higher IMO
Glta
$inai
$$$$$APH$$$$$
shareholder meeting 7 pm on friday
11/02/18 | 07:00pm Annual General Meeting
I realy hope this plays out like Canopy. It went hard down before they got their 4 billion invest..
yesterday many shares changed their owner
Good morning Mt69sinai - you right... they need to announce to reverse the slide. I am still hopeful they will before Friday.
Gd morn Day Grinder,,, I believe they need to asap 'if they have one',, for a reversal to take place,, I still believe we will open in the red but rebound a bit during the first hour into close,, I think they may 'possibly' announce a deal pre-market Friday in advance of AGM,,IMO of course.
Best of luck! And to all!
$inai
$$$$$APH$$$$$
I wonder if APH will announce a partnership before Friday?
APHRIA TO COMMENCE TRADING ON THE NYSE ON NOVEMBER 2; SLUMPED 17.35% ON TSX, MONDAY
LESS THAN 1 MINUTE AGO BY
Article 1Article 2Article 3Article 4Article 5Article 6Article 7Article 8Article 9Article 10
07:07 AM EDT, 10/30/2018 (MT Newswires) -- Aphria Inc. (APH.TO) -- which slumped 17% on the TSX yesterday -- said Tuesday that its common shares have been approved for listing on the New York Stock Exchange and will commence trading effective the open of markets on November 2, 2018.
Aphria's shares will trade on the NYSE under ticker symbol 'APHA.' The company's ticker symbol on the Toronto Stock Exchange will also change from 'APH' to 'APHA,' effective November 2, 2018. Existing shares of Aphria, which previously traded on the OTCQB under the ticker symbol 'APHQF' will now trade on the NYSE.
"Listing on the NYSE provides Aphria with access to the largest equity market in the world, with increased exposure to a vast array of US institutional and retail investors. This strategic move aligns directly with our growth ambitions as we enter an elite peer group of respected, high-profile corporate brands listed on the NYSE," said Vic Neufeld, Aphria CEO.
Neufeld added: "We are excited to usher in a new era with the recent legalization of adult-use cannabis in Canada and as we aim to further expand our footing in exciting markets such as Latin America, the Caribbean and Europe. Aphria is well-positioned to capitalize on this fast-growing industry."
Price: 12.77, Change: -2.68, Percent Change: -17.35
Would be great Buddy :)
APH $$$$$$$
There is no set date....but Aurora got listed pretty quick.
Maybe the week after this?
__________________________________________________
Concerning ACB:
The stock had dropped 12% on Tuesday, as it debuted on the NYSE, and had fallen 24% the past six sessions.
I own no shares of Aurora.
i wonder if we still uplist this week....
Copy that...But I am in Aphria strictly for a bright tomorrow.
Made good money here and We all will make more.
“The stock market is a device for transferring money from the impatient to the patient” - Warren Buffett
Hopefully it plays out the way everyone wants.
A CEO naming names during negotiations is not something that sits well with me. He comes from Jamison vitamins. Built it up and was a great CEO there.
There is never a reason to name names of companies during talks unless you a literally pumping your stock.
Yes...Given that some thought earlier and You are about 98% correct.
Most times these deals happen when no one expects it.
Seems a little weird everyone seems to "know" that a Altria deal is coming.
If the reason people think they know is due to the ceo making statements then that's a massive problem and reminds me of the pink sheets.
I hope it does happen as it would be good for everyone , including my local area (Essex county ).
Why A Deal Between Altria And Aphria Makes Sense:
https://seekingalpha.com/article/4215461-deal-altria-aphria-makes-sense
Aphria is the preferred choice - trading at very attractive valuation multiples. Very informative article - must read.
https://grizzle.com/pot-stocks-plunge-post-legalization/
Followers
|
55
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1644
|
Created
|
12/15/14
|
Type
|
Free
|
Moderators |
Three months ended May 31, | Twelve months ended May 31, | |||||||
2016 | 2015 | 2016 | 2015 | |||||
$ 2,776,316 | $ 499,890 | Revenue | $ 8,433,929 | $ 551,430 | ||||
2,106,394 | 585,708 | Gross profit | 5,977,428 | 794,851 | ||||
2,069,007 | 296,461 | Adjusted gross profit | 5,982,074 | 331,858 | ||||
74.5 | % | 59.3 | % | Adjusted gross margin | 70.9 | % | 60.2 | % |
102,164 | (481,380 | ) | Earnings (loss) before tax | (802,039 | ) | (6,543,444 | ) | |
1,302,164 | (481,380 | ) | Net income (loss) | 397,961 | (6,543,444 | ) | ||
520,685 | (642,295 | ) | EBITDA | 572,888 | (3,560,899 | ) |
Q4-2016 | Q3-2016 | |
4,675 | Patient registrations | 4,000 |
340.4 | Kilograms sold | 322.4 |
$ 1.15 | Cash cost to produce / gram | $ 1.67 |
$ 2.07 | "All-in" cost of goods sold / gram | $ 2.22 |
$ 16,472,664 | Cash and cash equivalents on hand | $ 12,053,547 |
$ 20,533,355 | Working capital | $ 15,868,075 |
$ 434,602 | Investment in capital assets | $ 1,175,007 |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |